The goal of this clinical trial is to learn if a 12-week Baduanjin exercise program can improve health in sedentary young and middle-aged adults. The main questions it aims to answer are: 1. Does the Baduanjin program improve participants' cardiorespiratory fitness (measured as peak oxygen uptake)? 2. Does it improve their body composition, muscle strength, balance, and flexibility? 3. Does it reduce their daily sitting time? Researchers will compare the Baduanjin training group to a health education control group to see if Baduanjin is more effective in improving these health outcomes. Participants will: 1. Be randomly assigned to one of the two groups. 2. If in the Baduanjin group, attend supervised group sessions and practice at home for 12 weeks. 3. Complete a series of assessments at the beginning, middle, and end of the study, including fitness tests, body measurements, and questionnaires.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
208
A 12-week, standardized Baduanjin exercise program. Participants will complete 5 sessions per week, each lasting 60 minutes (including warm-up, Baduanjin practice, and cool-down). The program includes both supervised group sessions and guided home practice.
Participants will receive general health education (including recommendations on physical activity types and duration), but will not be enrolled in any structured or supervised exercise program. They will be instructed to maintain their usual lifestyle.
Change in Peak Oxygen Uptake (VO₂peak) assessed by Cardiopulmonary Exercise Testing
Measured by Cardiopulmonary Exercise Testing (CPET).
Time frame: at baseline and Week 13.
Change in Sit-and-Reach Distance
Assessed by the standard sit-and-reach test.
Time frame: at baseline, Week 8, and Week 13.
Change in Active Range of Motion of the Shoulder, Hip, Knee, and Ankle joints assessed by Goniometry
Measured using a goniometer
Time frame: at baseline, Week 8, and Week 13.
Change in Time Spent in Sedentary Behavior assessed by the International Physical Activity Questionnaire (IPAQ)
Time frame: at baseline and Week 13.
Scores on the Exercise Benefits/Barriers Scale (EBBS)
The scale consists of two subscales: the Exercise Benefits Subscale (29 items) and the Exercise Barriers Subscale (14 items). The total score ranges from 43 to 172, with a higher score indicating a more positive perception towards exercise.
Time frame: at baseline and Week 13
Change in Knee Extension Peak Torque assessed by Isokinetic Dynamometry
Maximum torque generated during knee extension
Time frame: at baseline, Week 8, and Week 13.
Change in Knee Extension Total Work assessed by Isokinetic Dynamometry
Total work performed during repeated maximal knee extension contractions.
Time frame: at baseline, Week 8, and Week 13.
Change in Knee Extension Average Power assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13.
Change in Knee Extension Fatigue Index assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13.
Change in Knee Flexion Peak Torque assessed by Isokinetic Dynamometry
Maximum torque generated during Knee Flexion measured at a preset angular velocity
Time frame: at baseline, Week 8, and Week 13
Change in Knee Flexion Total Work assessed by Isokinetic Dynamometry
Total work performed during repeated maximal Knee Flexion contractions
Time frame: at baseline, Week 8, and Week 13
Change in Knee Flexion Average Power assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Knee Flexion Fatigue Index assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Shoulder Flexion Peak Torque assessed by Isokinetic Dynamometry
Maximum torque generated during Shoulder Flexion, measured at a preset angular velocity.
Time frame: at baseline, Week 8, and Week 13
Change in Shoulder Flexion Total Work assessed by Isokinetic Dynamometry
Total work performed during repeated maximal Shoulder Flexion contractions
Time frame: at baseline, Week 8, and Week 13
Change in Shoulder Flexion Average Power assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Shoulder Flexion Fatigue Index assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Shoulder Abduction Peak Torque assessed by Isokinetic Dynamometry
Maximum torque generated during Shoulder Abduction , measured at a preset angular velocity
Time frame: at baseline, Week 8, and Week 13
Change in Shoulder Abduction Total Work assessed by Isokinetic Dynamometry
Total work performed during repeated maximal Shoulder Abduction contractions
Time frame: at baseline, Week 8, and Week 13
Change in Shoulder Abduction Average Power assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Shoulder Abduction Fatigue Index assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Elbow Extension Peak Torque assessed by Isokinetic Dynamometry
Maximum torque generated during Elbow Extension, measured at a preset angular velocity
Time frame: at baseline, Week 8, and Week 13
Change in Elbow Extension Total Work assessed by Isokinetic Dynamometry
Total work performed during repeated maximal Elbow Extension contractions
Time frame: at baseline, Week 8, and Week 13
Change in Elbow Extension Average Power assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Elbow Extension Fatigue Index assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Elbow Flexion Peak Torque assessed by Isokinetic Dynamometry
Maximum torque generated during Elbow Flexion, measured at a preset angular velocity
Time frame: at baseline, Week 8, and Week 13
Change in Elbow Flexion Total Work assessed by Isokinetic Dynamometry
Total work performed during repeated maximal Elbow Flexion contractions
Time frame: at baseline, Week 8, and Week 13
Change in Elbow Flexion Average Power assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Elbow Flexion Fatigue Index assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Rhythmic Weight Shift (RWS) Score assessed by Computerized Dynamic Posturography
Measured using a computerized dynamic posturography system.
Time frame: at baseline, Week 8, and Week 13.
Change in Modified Clinical Test of Sensory Interaction on Balance (mCTSIB) Score assessed by Computerized Dynamic Posturography
Measured using a computerized dynamic posturography system.
Time frame: at baseline, Week 8, and Week 13.
Change in Sensory Organization Test (SOT) Composite Score assessed by Computerized Dynamic Posturography
Measured using a computerized dynamic posturography system.
Time frame: at baseline, Week 8, and Week 13.
Change in Motor Control Test (MCT) Latency assessed by Computerized Dynamic Posturography
Measured using a computerized dynamic posturography system.
Time frame: at baseline, Week 8, and Week 13.
Change in Limits of Stability (LOS) Score assessed by Computerized Dynamic Posturography
Measured using a computerized dynamic posturography system.
Time frame: at baseline, Week 8, and Week 13.
Change in Muscle Mass assessed by Bioelectrical Impedance Analysis
Time frame: at baseline and Week 13.
Change in Body Fat Percentage assessed by Bioelectrical Impedance Analysis
Time frame: at baseline and Week 13.
Change in Fat-Free Mass assessed by Bioelectrical Impedance Analysis
Time frame: at baseline and Week 13.
Change in Waist-to-Hip Ratio
Ratio of waist circumference to hip circumference
Time frame: at baseline and Week 13.
Change in Center of Mass Sway Amplitude during Baduanjin Exercise assessed by 3D Motion Capture
Magnitude of anteroposterior and mediolateral displacement of the body's center of mass during static postures of Baduanjin, analyzed using a markerless 3D motion capture system
Time frame: at baseline and Week 13
Change in Joint Range of Motion during Baduanjin Exercise assessed by 3D Motion Capture
Angular displacement of primary joints during the performance of Baduanjin movements, analyzed using a markerless 3D motion capture system.
Time frame: at baseline and Week 13
Change in Center of Mass Height during Baduanjin Exercise assessed by 3D Motion Capture
Time frame: at baseline and Week 13
Change in Integrated Electromyography (iEMG) during Baduanjin Exercise assessed by Surface Electromyography
Time frame: at baseline and Week 13
Change in Root Mean Square (RMS) Amplitude during Baduanjin Exercise assessed by Surface Electromyography
Time frame: at baseline and Week 13
Change in Glycemic Control Biomarkers
Fasting venous blood samples will be analyzed for indicators of glucose metabolism, such as glycated hemoglobin (HbA1c) and fasting insulin.
Time frame: at baseline and Week 13.
Change in Lipid Profile
Fasting venous blood samples will be analyzed for indicators of lipid metabolism, including total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C).
Time frame: at baseline and Week 13.
Change in Inflammatory and Neurotrophic Biomarkers
Fasting venous blood samples will be analyzed for inflammatory markers (e.g., high-sensitivity C-reactive protein \[hs-CRP\], interleukin-6 \[IL-6\], tumor necrosis factor-alpha \[TNF-α\]) and brain-derived neurotrophic factor (BDNF).
Time frame: at baseline and Week 13.
Percentage of Prescribed Baduanjin Sessions Completed
Time frame: Through study completion, up to Week 13.
Baduanjin Movement Quality Score assessed by Blinded Expert Review (100-point scale)
Score assessed by blinded experts using a standardized 100-point scoring rubric. Scores range from 0 to 100, with a higher score indicating better movement quality.
Time frame: at Week 13
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.